Engineering translational and physiologically relevant preclinical cancer models to advance women’s health research
The de la Puente Lab develops translational and physiologically relevant preclinical cancer models as tools to recapitulate tumor behavior ex vivo (“out of the living”) with an emphasis in cellular crosstalk, extracellular matrix remodeling, and spatial gradients. We focus on elucidating mechanisms driving chemoresistance and immune evasion in women’s cancer and further developing novel treatment strategies to mitigate their occurrence. Our long-term goal is to accelerate and directly translate our significant insights to aid women suffering from cancer.
Lab News
Grant Alert!!
The lab has been awarded a 4 year American Cancer Society Research Scholar Grant. We will work on a novel biomarker panel for early detection of ovarian cancer and markers associated with chemoresistance. #Excited #ACS #OvarianCancer #SanfordResearch
Congratulations Dr. Jorgensen for a successful thesis defense.
Megan is the first student to defend a thesis from the lab. #WomenInSTEM # MDPhD
Dr. de la Puente was selected as ResearchHERS Scholar, American Cancer Society.
A distinguished honor recognizing trailblazing women researchers based on their innovation and potential for impact. Thank you to the American Cancer Society for the recognition.
Dr. de la Puente is featured in the Comic Book Cancer Wars to bring contemporary role models for Hispanic women.
